Protalix BioTherapeutics Inc. (DE) News
Protalix Bio Cystic Fibrosis Drug Study Results Worsen Over Time
The Protalix medicine alidornase alfa is designed to help cystic fibrosis patients clear their lungs by making mucus thin and loose.
Biotech Stock Mailbag: Bulls love a distracted Trump, Protalix, Acadia, Sarepta
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Why Protalix BioTherapeutics (PLX) Stock Is Surging Today
Protalix BioTherapeutics (PLX) advanced Thursday after the company co-announced with Pfizer (PFE) that the FDA had approved the expansion of ELELYSO for injection in pediatric patients.
3 Mistakes to Avoid When Buying Disney World Tickets
If you're planning to visit Magic Kingdom, Epcot, Hollywood Studios, or Animal Kingdom, you need to know these things first.
Amid Twitter Chaos, Elon Musk Begs Readers for This One Thing
After a wild period before and after the official purchase of Twitter, the company's new CEO settles on a request he has of the microblogging site's users.
Royal Caribbean's CEO Shares an Emotional Take on Covid Closures
Covid caused a long dark period for the cruise industry from March 2020 through July 2021. Michael Bayley talks about what that time was like.
Elon Musk Shares How Twitter Handled the Hunter Biden 'Story'
Musk refers to "suppression by Twitter" of story about President Biden's surviving son.